We assessed whether the presence of central sleep apnea is associated with adverse left ventricular structural changes. We analysed 1412 participants from the Multi-Ethnic Study of Atherosclerosis who underwent both overnight polysomnography and cardiac magnetic resonance imaging. Subjects had been recruited 10 years earlier when free of cardiovascular disease. Our main exposure is the presence of central sleep apnea as defined by central apnea-hypopnea index = 5 or the presence of Cheyne-Stokes breathing. Outcome variables were left ventricular mass/height, left ventricular ejection fraction, and left ventricular mass/volume ratio. Multivariate linear regression models adjusted for age, gender, race, waist circumference, tobacco use, hypertension, and the obstructive apnea-hypopnea index were fit for the outcomes. Of the 1412 participants, 27 (2%) individuals had central sleep apnea. After adjusting for covariates, the presence of central sleep apnea was significantly associated with elevated left ventricular mass/volume ratio (b = 0.11 AE 0.04 g mL À1 , P = 0.0071), an adverse cardiac finding signifying concentric remodelling.
IN TROD UCTI ON
There is a high prevalence of central sleep apnea (CSA) in patients with co-morbid heart failure (HF). CSA is associated with increased morbidity and mortality in HF patients # ADDIN EN.CITE # ADDIN EN.CITE.DATA # (Khayat et al., 2015; Nakamura et al., 2015) . What is less understood is whether in a general community sample, the presence of CSA is a marker for individuals with cardiac structural features such as subclinical left ventricular (LV) dysfunction. Further, recent evidence suggests that CSA may be present prior to development of clinically overt HF (Javaheri et al., 2016) . Using rigorously obtained measures from cardiac magnetic resonance imaging (cMRI), we sought to address whether the presence of CSA on overnight polysomnography (PSG) is a marker for reduced LV function and adverse structural changes. We conducted an analysis of crosssectional data from the Multi-Ethnic Study of Atherosclerosis (MESA) to study the association of CSA with LV structure and function in an ethnically diverse, community-based sample. We hypothesized that an incidental finding of CSA would be significantly associated with reduced LV ejection fraction (LVEF), and elevated LV mass/volume ratio (LVMVR) and LV mass adjusted for body height in metres (LVHi).
MAT ERIALS AN D METH ODS

Study design and population
The MESA is a prospective multicentre study designed to detect subclinical markers of cardiovascular disease (CVD) in an ethnically diverse, population-based cohort. The study design has been published # ADDIN EN.CITE # ADDIN EN.CITE.DATA # (Bild et al., 2002) . Briefly, individuals aged 45-84 years, initially free of CVD, were recruited from six different US sites (Baltimore, MD; Chicago, IL; Forsyth County, NC; Los Angeles County, CA; Northern Manhattan, NY; and St Paul, MN) and underwent five exams at 2-year intervals beginning in 2000 -2002 . At exam 5 (2010 , participants underwent standardized anthropometric measurements (height, weight, waist circumference and resting blood pressure) and cMRI. Assessment of cMRI parameters was performed using CIM software (version 6.2, University of ª 2017 European Sleep Research Society Auckland, New Zealand) # ADDIN EN.CITE # ADDIN EN.CITE.DATA # (Young et al., 2000) , and the description of the cMRI methodology has been described # ADDIN EN.CITE # ADDIN EN.CITE.DATA # (Bild et al., 2002) . Also at exam 5, participants other than those reporting regular use of oral devices, nocturnal oxygen, or nightly positive airway pressure devices were invited to participate in the MESA Sleep Ancillary Study. Fifteen-channel, unattended, singlenight PSG (Somt e PSG, Compumedics, Abbotsford, Victoria, Australia) and sleep questionnaire data were collected during an in-home examination; details on sleep methodology are provided in prior publications # ADDIN EN.CITE # ADDIN EN.CITE.DATA # (Chen et al., 2014; Javaheri et al., 2015) . Our sample consisted of 1412 subjects from MESA exam 5 who had complete cMRI and PSG data. A more detailed description of the sample has been published (Javaheri et al., 2015) .
Covariates
Our primary exposure was CSA [defined as having a central apnea index (CAI) = 5 (all central apneas associated with a 4% desaturation/total sleep time) or presence of CheyneStokes breathing (CSB)]. CSB was defined as at least 10 min of crescendo decrescendo pattern of breathing during sleep. Our primary cMRI outcome was LVEF. Secondary outcomes were LVMVR and LVHi. LVMVR was derived by dividing the LV mass in grams by end-diastolic volume in millilitres. Covariates included pack years of smoking (by self-report), systolic blood pressure, diastolic blood pressure or use of anti-hypertensive medications, and the obstructive apneahypopnea index (AHI; all obstructive apneas plus hypopneas associated with = 4% desaturation/total sleep time). Blood pressure was obtained in triplicate in the right arm after 5 min rest in a seated position with a Dinamap automated device, and the average of the second and third measurements analysed. The periodic limb movement arousal index was defined as the sum of periodic limb movements, each associated with an electroencephalogram arousal, per hour of sleep.
Statistical analysis
Between-group differences were compared using Fisher's Exact Test for categorical variables and the two-sample t-test for continuous variables. If a continuous variable was highly skewed, a Wilcoxon Rank Sum test was used. Multivariable linear regression models adjusted for age, gender, race, waist circumference, smoking pack years, obstructive AHI and hypertension were used to quantify associations between CSA and MRI outcomes. A P-value of 0.05 was considered significant. SAS 9.3 (SAS Institute, Cary, NC, USA) was used to conduct analyses.
The study protocol was approved by an Institutional Review Board at all participating institutions, and written informed consent was obtained from all participants. Table 1 describes sample characteristics by the presence or absence of CSA. Overall sample characteristics are already published (Javaheri et al., 2015) . The sample had a mean age of 67 years, approximately 46% were male, and the sample was ethnically diverse with 38% white, 26% black, 22% Hispanic and 13% Chinese. Approximately 7% were smokers, 54% had self-reported hypertension and 14% had diabetes. Reflecting the community sample and cohort design (free of known CVD at exam 1), only 23 participants (1.5% of the sample) had an LVEF < 45%. CSA was identified in 27 participants (approximately 2%, comparable to other community samples; Donovan and Kapur, 2016) . Mean CAI was 5.1 AE 5.5 (range: 0-19) in those with CSA, with seven meeting the CSA definition because of the occurrence of CSB with a low CAI. Of the 27 participants with CSA, 20 also had at least moderate obstructive sleep apnea (OSA; an obstructive AHI = 15). Compared with those without CSA, those with CSA were significantly older, more likely to be male, had increased pack-years of smoking, lower waist circumference, and a higher obstructive AHI. There were no significant differences in race, hypertension, alcohol use, diabetes or periodic limb movement index between groups.
RESULTS
In unadjusted analysis, LVMVR was significantly associated with the presence of CSA (P = 0.0007), but not LVEF or LVHi. After adjustment for age, gender, race, waist circumference, smoking pack-years, systolic and diastolic blood pressure, use of anti-hypertensive medications, and obstructive AHI, CSA remained significantly associated with LVMVR (b = 0.10 AE 0.09 g mL À1 , P = 0.015), and again there were no significant associations between CSA and LVEF or LVHi. Obstructive AHI, however, was not associated with LVMVR after adjusting for CSA (P = 0.08).
DISCUSSION
To our knowledge, this is the first investigation to quantify associations between CSA (defined by an elevated CAI or CSB) and LV structure in a community-based population free of CVD when recruited into the cohort study. Prior work assessing CSA and LV structure has done so in a population with known HF and using echocardiography # ADDIN EN.CITE # ADDIN EN.CITE.DATA # (Kourouklis et al., 2013) . Our results demonstrate that in an ethnically diverse community-based cohort, after adjusting for potential confounders including OSA, the presence of CSA is significantly associated with increasing LVMVR. A positive association between CSA and LVMVR is of particular interest given that higher LVMVR signifies concentric remodelling that usually occurs in response to haemodynamic stress and is a predictor of worse cardiovascular outcomes # ADDIN EN.CITE # ADDIN EN.CITE.DATA # (Bluemke et al., 2008) . LVMVR is closely associated with functional markers of early LV dysfunction, including LV circumferential and global longitudinal strain and dyssynchrony # ADDIN (Choi et al., 2013; Sharma et al., 2014) . These changes precede onset of clinical HF, and confer significant morbidity and mortality burden. Of particular interest is the reported higher prevalence of HF with preserved ejection fraction (HFpEF), characterized by diastolic dysfunction # ADDIN EN.CITE # ADDIN EN.CITE.DATA # (Katz et al., 2013) among those with CSA. As suggested in our analysis, this may be potentially mediated by unfavourable LV remodelling and associated cardiac functional deterioration. Our results also demonstrate that in this community-based cohort, there was no significant association between CSA and LVHi or LVEF. The lack of a significant association between CSA and LVEF likely reflects the low prevalence of both CSA and reduced LVEF in this cohort, a consequence of the study design and low prevalence of clinically overt CVD in the sample. CSA in the absence of HF may represent several entities, including augmented chemoreflex # ADDIN EN.CITE # ADDIN EN.CITE.DATA # (Xie et al., 1995) , subclinical HF or idiopathic CSA. As the MESA cohort is followed for incident CVD, there will be opportunities to further follow the prognostic value of CSA as an indicator of incident HF, and whether those with CSA and elevated LVMVR have increased risk of HFpEF.
The strengths of this study include the use of a large, community-based sample of ethnically diverse women and men recruited free of baseline CVD, as well as use of standardized and objective PSG and cMRI measures. The limitations include the cross-sectional design as well as the relatively low prevalence of both CSA and reduced LVEF, a reflection of a cohort free of CVD at the time of recruitment. However, the prevalence of CSA in this sample is comparable to that of other community samples, such as the Sleep Heart Health Study (Donovan and Kapur, 2016) . Additionally, information to further characterize CSA (such as history of opiate use, duration of CSB and cycle length) was not available. The frequent co-occurrence of CSA and OSA in the majority of this sample prevented us from examining a 'pure' CSA phenotype, and makes the findings more difficult to interpret. Nonetheless, the association with LVMVR was with CSA in models adjusting for the obstructive AHI, and the obstructive AHI was not associated with LVMVR.
CONC LUSIONS
In an ethnically diverse community-based sample of adults initially recruited to be free of clinical CVD, participants with CSA have higher LVMVR suggestive of concentric modelling. 
